<DOC>
	<DOCNO>NCT00947895</DOCNO>
	<brief_summary>The purpose study compare intramuscular ( IM ) ACTH ( adrenocorticotropin hormone ) intravenous ( IV ) methylprednisolone ( Solumedrol ) treatment MS ( Multiple Sclerosis ) relapse ( exacerbation ) sub-response initial 3 day course IV methylprednisolone .</brief_summary>
	<brief_title>Efficacy Study Adrenocorticotropin Hormone Treat Multiple Sclerosis ( MS ) Relapses After Sub-responding Initial 3 Day Course Intravenous ( IV ) Methylprednisolone</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>male female female childbearing potential must : negative pregnancy test prior entry Doubleblind Treatment Phase agree use adequate contraception treatment . female either postmenopausal 12 month prior randomization surgically sterile ( document ) , may include without requirement ≥ 18 year age sign write informed consent prior participate study ( Appendix 1 ) willing able comply trial requirement , include visit schedule completion scale diagnosis multiple sclerosis 2005 revise McDonald criterion ( Appendix 3 ) Expanded Disability Status Scale ( EDSS ) score 06.0 inclusive currently take stable dose injectable MS disease modify agent precede 6 month great prior studyentry relapse opinion treat physician undergo 3 5 day course IV methylprednisolone manifestation MS relapse initial IV MP great 14 day start present relapse history chronic disease immune system MS know immunodeficiency syndrome know 'new ' diagnosis diabetes mellitus ( screen blood glucose suspicious diabetes [ ≥126 mg/dL ≥7 mmol/L fasting ; ≥200 mg/dL 11.1 mmol/L random test ] patient evaluate diabetes mellitus ) contraindication steroid therapy , e.g. , peptic ulcer , psychotic state severe hypertension sensitivity proteins porcine origin know 'new ' diagnosis severe depression define score great 30 Beck Depression Inventory ( BDI ) know 'new ' diagnosis hypothyroidism adequately controlled medication treatment Natalizumab past 6 month active systemic bacterial , viral fungal infection , diagnosis AIDS , Hepatitis B , Hepatitis C infection define positive HIV antibody , Hepatitis B surface antigen Hepatitis C antibody test , respectively receive total lymphoid irradiation bone marrow transplantation treat corticosteroid adrenocorticotropic hormone ( ACTH ) within 1 month prior PreRandomization Phase medically unstable condition , assess primary treat physician follow neurologic/psychiatric disorder : history substance abuse ( drug alcohol ) factor ( i.e. , serious psychiatric condition ) may interfere subject 's ability cooperate comply study procedure ; progressive neurological disorder , MS , may affect participation study require use medication allow protocol follow abnormal laboratory value : serum creatinine great 1.7 mg/dL ( 150 μmol/L ) white blood cell ( WBC ) count &lt; 3,500/mm3 ( &lt; 3.5 X 109 / L ) lymphocyte count &lt; 800/mm3 ( &lt; 0.8 X 109 / L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ACTH</keyword>
	<keyword>Acthar gel</keyword>
	<keyword>adrenocorticotropin</keyword>
	<keyword>methylprednisolone</keyword>
	<keyword>solumedrol</keyword>
	<keyword>MS</keyword>
	<keyword>multiple</keyword>
	<keyword>sclerosis</keyword>
	<keyword>relapse</keyword>
	<keyword>exacerbation</keyword>
	<keyword>sub-responsive</keyword>
	<keyword>IV</keyword>
</DOC>